Forcefield Therapeutics Launched With ‘Gamechanger’ Goal For Post-MI Therapy
Led By Ex-Sandoz Head Richard Francis
Executive Summary
The newly launched biotech has a novel platform for discovering protective tissue factors and turning them into therapies,with heart failure prevention its first target.